INDUCIBLE NUCLEAR FACTOR BINDING TO THE KAPPA-B-ELEMENTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENHANCER IN T-CELLS CAN BE BLOCKED BY CYCLOSPORINE-A IN A SIGNAL-DEPENDENT MANNER

被引:74
作者
SCHMIDT, A
HENNIGHAUSEN, L
SIEBENLIST, U
机构
[1] NIAID,IMMUNOREGULAT LAB,BETHESDA,MD 20892
[2] NIDDKD,BIOCHEM & METAB LAB,BETHESDA,MD 20892
关键词
D O I
10.1128/JVI.64.8.4037-4041.1990
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:4037 / 4041
页数:5
相关论文
共 29 条
[1]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[2]   THE SAME INDUCIBLE NUCLEAR PROTEINS REGULATES MITOGEN ACTIVATION OF BOTH THE INTERLEUKIN-2 RECEPTOR-ALPHA GENE AND TYPE-1 HIV [J].
BOHNLEIN, E ;
LOWENTHAL, JW ;
SIEKEVITZ, M ;
BALLARD, DW ;
FRANZA, BR ;
GREENE, WC .
CELL, 1988, 53 (05) :827-836
[3]  
BOHNLEIN E, 1989, J VIROL, V63, P1578
[4]  
BRUNVAND MW, 1988, J BIOL CHEM, V263, P18904
[5]   COMPARISON OF THE WHEY ACIDIC PROTEIN GENES OF THE RAT AND MOUSE [J].
CAMPBELL, SM ;
ROSEN, JM ;
HENNIGHAUSEN, LG ;
STRECHJURK, U ;
SIPPEL, AE .
NUCLEIC ACIDS RESEARCH, 1984, 12 (22) :8685-8697
[6]   CHARACTERIZATION OF ANTIGEN RECEPTOR RESPONSE ELEMENTS WITHIN THE INTERLEUKIN-2 ENHANCER [J].
DURAND, DB ;
SHAW, JP ;
BUSH, MR ;
REPLOGLE, RE ;
BELAGAJE, R ;
CRABTREE, GR .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (04) :1715-1724
[7]   CYCLOSPORINE-A SPECIFICALLY INHIBITS FUNCTION OF NUCLEAR PROTEINS INVOLVED IN T-CELL ACTIVATION [J].
EMMEL, EA ;
VERWEIJ, CL ;
DURAND, DB ;
HIGGINS, KM ;
LACY, E ;
CRABTREE, GR .
SCIENCE, 1989, 246 (4937) :1617-1620
[8]   CHARACTERIZATION OF CELLULAR PROTEINS RECOGNIZING THE HIV ENHANCER USING A MICROSCALE DNA-AFFINITY PRECIPITATION ASSAY [J].
FRANZA, BR ;
JOSEPHS, SF ;
GILMAN, MZ ;
RYAN, W ;
CLARKSON, B .
NATURE, 1987, 330 (6146) :391-395
[9]   LYMPHOKINE AND NONLYMPHOKINE MESSENGER-RNA LEVELS IN STIMULATED HUMAN T-CELLS - KINETICS, MITOGEN REQUIREMENTS, AND EFFECTS OF CYCLOSPORINE-A [J].
GRANELLIPIPERNO, A ;
ANDRUS, L ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (04) :922-937
[10]  
GUNTER KC, 1989, J IMMUNOL, V142, P3286